from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0321/dcd

LFCtreatmentdescriptionclass of inhibitor

0.003

Amikacinug/mL Amikacintranslation

0.167

Cap5-10ug/mL Capreomycintranslation

0.043

Rox10-50 ug/mL Roxithromycintranslation

0.200

SM2-5 ug/mL Streptomycintranslation

0.297

Tet5-10 ug/mL Tetracyclinetranslation

0.641

Rif0.2-5ug/mL Rifampicintranscription

0.069

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.507

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.171

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-1.186

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.672

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.817

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.192

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.390

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.887

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.456

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.603

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.592

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.199

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.901

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.634

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

0.892

Nigericin50 uM Nigericinrespiration

-0.386

TRC10-150 ug/mL Triclosanrespiration

-0.998

TRZ10-25 ug/mL Thioridazinerespiration

-1.368

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.893

menadione6-10 ug/mL Menadionerespiration

0.434

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.166

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.943

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

1.284

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.304

NRP_1Non-replicating persistence stage 1dosRassociated

-0.295

Amp0.2mg/mL AmpicillincellWall

0.235

Cephalexin20-100 ug/mL CephalexincellWall

0.072

Cerulenin0.32-5 ug/mL CerulenincellWall

0.981

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.237

EMB10-20 ug/mL EthambutolcellWall

0.379

Eta12-40 ug/mL EthionamidecellWall

0.368

INH0.2-0.4 ug/mL IsoniazidcellWall

0.293

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.235

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.174

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.079

BZA0.12 mg/mL BenzamidearomaticAmides

-0.402

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.513

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.313

H2O24 mM hydrogen peroxideDNAdamaging

-0.060

Levo10 ug/mL LevofloxacinDNAdamaging

0.433

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.647

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.382

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.073

UVUV-irradiationDNAdamaging

-0.887

ARP41-4 ug/mL Antitubercular compound ARP4?

0.111

Antimycin12.5-50 ug/mL Antimycin A?

0.118

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.171

PA_110-50 ug/mL Antitubercular compound PA-1?

0.228

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.571

PA8240.2-2 ug/mL PA-824?

-0.441

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.178

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.848

Verapamil50 uM Verapamil?

0.858

mercaptoethanol2 mM 2-Mercaptoethanol?

0.437

methoxatin10-20 ug/mL Methoxatin?